|
|||||
|
In the United States skin cancer is the most prevalent form of cancer, and melanoma is the most lethal type of skin cancer. According to two studies conducted by the Centers for Disease Control and Prevention and the National Cancer Institute, young adults are increasing their risk for developing the disease… View full post on Melanoma / Skin Cancer News From Medical . . . → Read More: Sunburn Common Among Young Adults, USA At Moffitt Cancer Center, patients with stage III and IV unresectable melanoma are now routinely genetically profiled for several gene mutations, including the BRAF gene, a known driver oncogene for melanoma. Research has shown that mutations in the BRAF gene determine sensitivity or resistance to a class of drugs that are BRAF inhibitors… View full post on Melanoma / Skin Cancer News From Medical . . . → Read More: Researchers Working At Frontiers Of Melanoma Research According to an evaluation of Medicare beneficiaries, there has been a significant increase in surgical treatment for nonmelanoma skin cancer (NMSC), from 2001 until 2006. The study, published in the April issue of Archives of Dermatology, states that the increase is primarily due to a doubling in the rate of Mohs micrographic surgery procedures… View full post on Melanoma / Skin Cancer News From Medical . . . → Read More: Surgical Procedures For Skin Cancer Via Medicare Examined A new study of mice reported at a meeting in Chicago this week, suggests caffeine and exercise may cut the risk of developing skin cancers caused by exposure to the sun… View full post on Melanoma / Skin Cancer News From Medical . . . → Read More: Caffeine, Exercise May Cut Skin Cancer Risk At the 2012 Society of Surgical Oncology Annual Meeting, Provectus Pharmaceuticals Inc. presented non-clinical information on PV-10s immunologic mechanism, which confirms that the drug’s chemoablation of melanoma lesions results in a systemic response and initiates systemic anti-tumor immunity… View full post on Melanoma / Skin Cancer News From Medical . . . → Read More: Intralesional PV-10 Treatment Shows Promise For Some Melanoma Patients Article by Laura Mims Skin cancer is the most commonly diagnosed cancer for both women and men. The number of confirmed cases has steadily increased over the past few decades. Knowing your risk factors, how to identify the early stages of this disease and how to protect yourself from skin cancer is essential for early detection and effective treatment. There are two types of skin cancer: melanomas and keratinocyte cancers. Melanomas are less common yet more serious than other types of skin cancer. It is important that you locate and receive treatment for all types of this cancer to prevent the spread into surrounding tissues.A major risk factor for skin cancer is exposure to ultraviolet (UV) rays from sunlight or tanning beds. UV rays can penetrate the skin even when it is cloudy, cool or hazy outside. There are some things you can do to limit your sun exposure. Many physicians recommend daily use of sunscreen. You should seek shade when spending time outdoors and try to avoid activities outside when the sun’s rays are strongest, usually between 10am and 4 pm. Hats, sunglasses and protective clothing protect your skin from UV exposure. Stay away from indoor tanning beds as they have been linked to melanoma and squamous cell skin cancers. Individuals with fair skin that freckles and burns easily are at a . . . → Read More: Skin Cancer Risk Factors and Prevention An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation… View full post on Melanoma / Skin Cancer News From Medical . . . → Read More: Vemurafenib Extends Survival To 16 Months For Some Patients With Metastatic Melanoma A rarely seen phenomenon in cancer patients – in which focused radiation to the site of one tumor is associated with the disappearance of metastatic tumors all over the body – has been reported in a patient with melanoma treated with the immunotherapeutic agent ipilimumab (Yervoy™)… View full post on Melanoma / Skin Cancer News From Medical . . . → Read More: Following Local Radiation Treatment, Rare Medical Phenomenon Of Systemic Tumor Disappearance Reported In A Patient With Metastatic Melanoma The University of Kentucky has announced that Dr. Daret St. Clair, the James Graham Brown Endowed Chair and professor of toxicology, has published the first comprehensive study that provides insight into the relationship between two types of suppressors in cancerous tumors. The results will enhance the understanding of transcriptional mechanisms in carcinogenesis… View full post on Melanoma / Skin Cancer News From Medical . . . → Read More: Insight Into Cancer Progression The National Cancer Institute (NCI) estimates that as many as one in 51 men and women will be diagnosed with melanoma – the deadliest form of skin cancer – at some point during their lifetimes. A research team led by Ze’ev Ronai, Ph.D… View full post on Melanoma / Skin Cancer News From Medical . . . → Read More: Study Identifies Molecular Switch That Allows Melanoma To Resist Therapy |
|||||
|
Copyright © 2012 ballochroy.com - All Rights Reserved
Powered by Yahoo! Answers Powered by Yahoo! Answers |
|||||
New comments